AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| 1 |
Eli Lilly
LLY
|
+$882M |
| 2 |
Waters Corp
WAT
|
+$415M |
| 3 |
UnitedHealth
UNH
|
+$402M |
| 4 |
Nike
NKE
|
+$350M |
| 5 |
Ferrari
RACE
|
+$313M |
Top Sells
| 1 |
Home Depot
HD
|
+$486M |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$463M |
| 3 |
NextEra Energy, Inc.
NEE
|
+$416M |
| 4 |
PayPal
PYPL
|
+$322M |
| 5 |
Microsoft
MSFT
|
+$318M |
Sector Composition
| 1 | Technology | 26.55% |
| 2 | Healthcare | 18.19% |
| 3 | Financials | 12.11% |
| 4 | Consumer Discretionary | 10.55% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2851
InnovAge Holding
INNV
$577M
| $242K | ﹤0.01% |
30,300
+1,000
| +3% | +$7.98K |
|
2852
Citizens & Northern Corp
CZNC
$311M
| $242K | ﹤0.01% |
11,302
-200
| -2% | -$4.28K |
|
2853
Generation Bio
GBIO
$41.4M
| $240K | ﹤0.01% |
5,581
-110
| -2% | -$4.73K |
|
2854
Movado Group
MOV
$427M
| $239K | ﹤0.01% |
8,300
-5,345
| -39% | -$154K |
|
2855
Carriage Services
CSV
$669M
| $238K | ﹤0.01% |
7,800
| – | – |
|
2856
West Bancorporation
WTBA
$340M
| $238K | ﹤0.01% |
13,000
-300
| -2% | -$5.48K |
|
2857
Sutro Biopharma
STRO
$82.3M
| $237K | ﹤0.01% |
51,400
| – | – |
|
2858
Teekay
TK
$732M
| $237K | ﹤0.01% |
38,300
+12,700
| +50% | +$78.5K |
|
2859
Oppenheimer Holdings
OPY
$764M
| $235K | ﹤0.01% |
6,000
-1,000
| -14% | -$39.2K |
|
2860
Nkarta
NKTX
$147M
| $234K | ﹤0.01% |
66,000
| – | – |
|
2861
Hayward Holdings
HAYW
$3.39B
| $233K | ﹤0.01% |
19,906
-359
| -2% | -$4.21K |
|
|
TVRD
2862
Tvardi Therapeutics, Inc. Common Stock
TVRD
$298M
| $233K | ﹤0.01% |
1,317
-185
| -12% | -$32.7K |
|
|
SCU
2863
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $231K | ﹤0.01% |
26,800
-1,400
| -5% | -$12.1K |
|
2864
Seaboard Corp
SEB
$3.74B
| $230K | ﹤0.01% |
61
+1
| +2% | +$3.77K |
|
2865
TrueCar
TRUE
$190M
| $228K | ﹤0.01% |
99,300
| – | – |
|
2866
Douglas Elliman
DOUG
$240M
| $228K | ﹤0.01% |
77,082
-6,774
| -8% | -$20.1K |
|
2867
Viking Therapeutics
VKTX
$2.84B
| $227K | ﹤0.01% |
+13,656
| New | +$227K |
|
2868
Lexicon Pharmaceuticals
LXRX
$411M
| $227K | ﹤0.01% |
93,411
+3,600
| +4% | +$8.75K |
|
2869
Franklin Covey
FC
$238M
| $227K | ﹤0.01% |
5,900
-700
| -11% | -$26.9K |
|
2870
Gannett
GCI
$601M
| $226K | ﹤0.01% |
121,020
-21,573
| -15% | -$40.3K |
|
2871
Enlight Renewable Energy
ENLT
$3.84B
| $224K | ﹤0.01% |
+13,216
| New | +$224K |
|
2872
MidWestOne Financial Group
MOFG
$609M
| $224K | ﹤0.01% |
9,153
| – | – |
|
2873
Definitive Healthcare
DH
$431M
| $223K | ﹤0.01% |
21,552
-1,056
| -5% | -$10.9K |
|
2874
PMV Pharmaceuticals
PMVP
$84.8M
| $222K | ﹤0.01% |
46,500
+5,200
| +13% | +$24.8K |
|
2875
Southern Missouri Bancorp
SMBC
$635M
| $221K | ﹤0.01% |
5,900
+300
| +5% | +$11.2K |
|